查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1790313

深奧測試市場規模、佔有率和趨勢分析報告：按類型、技術、最終用途、地區和細分市場預測，2025 年至 2030 年

Esoteric Testing Market Size, Share & Trends Analysis Report By Type (Oncology Testing, Infectious Disease Testing, Infectious Genetic Testing), By Technology, By End Use (Hospital-based Laboratories) By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

深奧測試市場摘要

2024 年全球深度檢測市場規模估計為 246 億美元，預計到 2030 年將達到 479.8 億美元，2025 年至 2030 年的複合年成長率為 11.8%。這一市場成長是由對早期疾病診斷的需求不斷成長和癌症患病率上升所推動的，這推動了對更安全的診斷選擇的需求。

根據美國生物技術資訊中心 (NCBI) 的數據，預計到 2025 年，美國將確診約 2,041,910 例癌症病例，造成 618,120 人死亡。目前可用的深度檢測方案具有良好的成長潛力，且市場對技術先進且價格合理的檢測需求旺盛，預計將在未來幾年推動市場成長。此外，獨立實驗室和參考實驗室對先進深度檢測技術的採用預計將推動深度檢測產業的發展。

特殊檢測對於識別特定基因和生物標記以製定個人化治療計劃至關重要。例如，2023 年 2 月，羅氏宣布延長與楊森的合作關係，並進一步加強研究和創新活動，透過專注於伴隨診斷來推進個人化醫療。全球個人化醫療偏好日益成長，預計將在未來幾年推動產品需求。即時聚合酵素鏈鎖反應(PCR) 和次世代定序等技術進步正在推動外科醫生和患者對特殊檢測的偏好，預計這將成為高階診斷需求的主要驅動力。特殊診斷的例子包括罕見疾病的基因檢測、罕見感染疾病的專門檢測和高級生物標記檢測。與標準的血液和尿液檢查相比，特殊診斷通常委託擁有必要設備和人員的參考實驗室。由於這些測試具有很高的特異性和有效性，它們在某些治療環境和科學研究中很有價值。

個人化醫療的日益成長趨勢顯著增加了對特殊檢測的需求。這些專門的檢測會檢查患者的基因組成、蛋白質譜和生物標記，以確定針對每位患者的標靶治療。隨著人們對個人化醫療和精準診斷的認知不斷提高，對有針對性和客製化的檢測策略的需求也日益成長。政府舉措多地提供各種便利設施，包括診斷檢測報銷，預計也是推動市場發展的主要因素。許多醫療機構正在與實驗室合作，整合各種特殊檢測。

過去幾年，政府和私人保險公司提供的政策擴大了這些檢查的覆蓋範圍。因此，支持性的報銷和監管政策也是市場的主要驅動力。醫療保險（Medicare）和醫療補助（Medicaid）提高了各種特殊檢查的報銷額度。此外，私人保險公司正在與非製藥實驗室合作，為患者提供價格合理的檢查，從而降低患者的自付費用，並增加特殊檢查的可及性，進一步推動市場成長。

目錄

第1章調查方法與範圍

第2章執行摘要

3. 深奧測試市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 深奧的測試市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 深奧測驗市場：類型評估與趨勢分析

  • 類型細分儀表板
  • 深奧測試市場：類型變化分析
  • 全球深奧測試市場規模與趨勢分析（按類型）（2018-2030）
  • 腫瘤學檢測
  • 傳染病檢查
  • 基因檢測
  • 內分泌檢查
  • 毒性測試
  • 神經學檢查
  • 其他

第5章：深奧測驗市場：技術評估與趨勢分析

  • 技術細分儀表板
  • 深奧測試市場：技術變革分析
  • 全球深層測試市場規模與趨勢分析（按技術，2018-2030 年）
  • 化學冷光免疫檢測
  • 酵素免疫分析法
  • 質譜法
  • 即時聚合酵素鏈鎖反應
  • 流式細胞技術
  • 其他

6. 深奧測試市場：最終用途估計與趨勢分析

  • 類型細分儀表板
  • 深奧測試市場：最終用途變異分析
  • 全球綜合測試市場規模及趨勢分析（依最終用途，2018-2030）
  • 醫院附設檢查室
  • 獨立和參考實驗室
  • 其他

7. 深奧測試市場：區域估計與趨勢分析

  • 區域市場儀表板
  • 2024 年及 2030 年區域市場佔有率分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲（MEA）
    • 阿根廷
    • 南非
    • 南阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • Key Company Heat Map Analysis, 2024
  • 公司簡介
    • Labcorp.
    • OPKO HEALTH, INC.
    • Quest Diagnostics Incorporated
    • Sonic Healthcare Limited
    • HU Group Holdings, Inc.
    • Kindstar Globalgene Technology, Inc.
    • Stanford Health Care
    • Mayo Foundation for Medical Education and Research
    • ARUP Laboratories
    • Athena Esoterix
    • ACM Global Laboratories
    • Healius Limited.
Product Code: GVR-4-68040-272-6

Esoteric Testing Market Summary

The global esoteric testing market size was estimated at USD 24.6 billion in 2024 and is projected to reach USD 47.98 billion by 2030, growing at a CAGR of 11.8% from 2025 to 2030. The market growth can be attributed to the increasing demand for early disease diagnosis and the rising prevalence of cancer, which impels the demand for safer diagnostic options.

According to the National Center for Biotechnology Information (NCBI), around 2,041,910 cancer cases will be diagnosed, with 618,120 cancer deaths expected in the U.S. in 2025. The lucrative growth potential of currently available esoteric testing options and high demand for technologically advanced and affordable tests are the factors expected to drive the market growth in the coming years. Moreover, the adoption of advanced esoteric testing technologies in independent and reference laboratories is anticipated to drive the esoteric testing industry.

Esoteric tests are crucial in identifying particular genetic markers and biomarkers to develop personalized treatment plans. For instance, in February 2023, F. Hoffmann-La Roche Ltd announced the extension of its collaboration with Janssen to advance personalized healthcare by focusing on companion diagnostics, further strengthening research and innovation activities. Thus, the rising preference for personalized medicine worldwide is anticipated to boost product demand in the coming years. The growing inclination of surgeons and patients for esoteric tests due to technological advancements, such as real-time Polymerase Chain Reaction (PCR), next-generation sequencing, and others, is anticipated to be a key driver of the rising demand for advanced diagnostics. Examples of esoteric diagnostics are genetic tests for uncommon illnesses, specialized tests for unusual infections, and advanced biomarker assays. In contrast to standard blood or urine testing, esoteric diagnostics are usually outsourced to reference labs equipped with the necessary equipment and personnel. These tests can be beneficial in specific therapeutic settings or scientific investigations owing to their high specificity and effectiveness, even though the demand is usually low due to the high cost.

The growing trend toward personalized treatment has led to a significant increase in the need for esoteric tests. To identify targeted therapies specific to each patient, these specialized tests examine a patient's genetic composition, protein profiles, and biomarkers. With the growing adoption of personalized medicine and precision diagnostics due to increased awareness, targeted and customized testing strategies are becoming increasingly necessary. An increase in initiatives undertaken by the government to provide various facilities, such as reimbursement for diagnostic tests, is another major factor anticipated to drive the market. Many healthcare institutions are working with laboratories to integrate different esoteric tests.

Over the last few years, the coverage for these procedures by policies offered by government and private insurance providers has increased. Hence, supportive reimbursement and regulatory policies also act as key drivers of the market. Medicare and Medicaid have increased reimbursement for various esoteric tests. In addition, private insurers are collaborating with esoteric labs to offer patients affordable tests, which lower out-of-pocket costs for patients and increase access to esoteric tests, thereby driving market growth.

Esoteric Testing Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels as well as provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the esoteric testing market report on the basis of product, technology, and region:

  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Oncology testing
  • Infectious disease testing
  • Genetic testing
  • Endocrinology testing
  • Toxicology testing
  • Neurology testing
  • Others
  • Technology Outlook (Revenue, USD Million, 2018 - 2030)
  • Chemiluminescence immunoassay
  • Enzyme-linked immunosorbent assay
  • Mass spectrometry
  • Real time polymerase chain reaction
  • Flow cytometry
  • Others
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospital-based laboratories
  • Independent and reference laboratories
  • Other
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Technology
    • 1.2.3. End Use
    • 1.2.4. Regional Scope
    • 1.2.5. Estimates and Forecasts Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
    • 1.4.5. Details of Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type Outlook
    • 2.2.2. Technology Outlook
    • 2.2.3. End Use Outlook
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Esoteric Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Esoteric Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. Esoteric Testing Market: Type Estimates & Trend Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. Esoteric Testing Market: Type Movement Analysis
  • 4.3. Global Esoteric Testing Market Size & Trend Analysis, By Type, 2018 to 2030 (USD Million)
  • 4.4. Oncology Testing
    • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5. Infectious Disease Testing
    • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.6. Genetic Testing
    • 4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.7. Endocrinology Testing
    • 4.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.8. Toxicology Testing
    • 4.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.9. Neurology Testing
    • 4.9.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.10. Others
    • 4.10.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Esoteric Testing Market: Technology Estimates & Trend Analysis

  • 5.1. Technology Segment Dashboard
  • 5.2. Esoteric Testing Market: Technology Movement Analysis
  • 5.3. Global Esoteric Testing Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 5.4. Chemiluminescence Immunoassay
    • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5. Enzyme-linked Immunosorbent Assay
    • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6. Mass Spectrometry
    • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.7. Real Time Polymerase Chain Reaction
    • 5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.8. Flow Cytometry
    • 5.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Esoteric Testing Market: End Use Estimates & Trend Analysis

  • 6.1. Type Segment Dashboard
  • 6.2. Esoteric Testing Market: End Use Movement Analysis
  • 6.3. Global Esoteric Testing Market Size & Trend Analysis, By End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospital-based Laboratories
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5. Independent and Reference Laboratories
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6. Other
    • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Esoteric Testing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market Share Analysis, 2024 & 2030
  • 7.3. Continuous Bioprocessing Market By Region: Key Takeaways
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key Country Dynamics
      • 7.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.1.3. Competitive Scenario
      • 7.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key Country Dynamics
      • 7.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.1.3. Competitive Scenario
      • 7.5.1.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Denmark
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.6.3. Competitive Scenario
      • 7.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.7.3. Competitive Scenario
      • 7.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.8. Norway
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.8.3. Competitive Scenario
      • 7.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key Country Dynamics
      • 7.6.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.1.3. Competitive Scenario
      • 7.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.4. South Korea
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.7. Latin America
      • 7.7.1.1. Key Country Dynamics
      • 7.7.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.1.3. Competitive Scenario
      • 7.7.1.4. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.3.3. Competitive Scenario
      • 7.7.3.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.8. Middle East & Africa (MEA)
      • 7.8.1.1. Key Country Dynamics
      • 7.8.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.1.3. Competitive Scenario
      • 7.8.1.4. Middle East & Africa (MEA)Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.2.3. Competitive Scenario
      • 7.8.2.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.3. South Africa
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.3.3. Competitive Scenario
      • 7.8.3.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.4. South Arabia
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.4.3. Competitive Scenario
      • 7.8.4.4. South Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.5. UAE
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.5.3. Competitive Scenario
      • 7.8.5.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.6. Kuwait
      • 7.8.6.1. Key Country Dynamics
      • 7.8.6.2. Regulatory Framework/Reimbursement Structure
      • 7.8.6.3. Competitive Scenario
      • 7.8.6.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. Key Company Heat Map Analysis, 2024
  • 8.4. Company Profiles
    • 8.4.1. Labcorp.
      • 8.4.1.1. Company Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Type Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. OPKO HEALTH, INC.
      • 8.4.2.1. Company Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Type Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Quest Diagnostics Incorporated
      • 8.4.3.1. Company Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Type Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Sonic Healthcare Limited
      • 8.4.4.1. Company Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Type Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. H.U. Group Holdings, Inc.
      • 8.4.5.1. Company Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Type Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Kindstar Globalgene Technology, Inc.
      • 8.4.6.1. Company Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Type Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Stanford Health Care
      • 8.4.7.1. Company Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Type Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Mayo Foundation for Medical Education and Research
      • 8.4.8.1. Company Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Type Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. ARUP Laboratories
      • 8.4.9.1. Company Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Type Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Athena Esoterix
      • 8.4.10.1. Company Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Type Benchmarking
      • 8.4.10.4. Strategic Initiatives
    • 8.4.11. ACM Global Laboratories
      • 8.4.11.1. Company Overview
      • 8.4.11.2. Financial Performance
      • 8.4.11.3. Type Benchmarking
      • 8.4.11.4. Strategic Initiatives
    • 8.4.12. Healius Limited.
      • 8.4.12.1. Company Overview
      • 8.4.12.2. Financial Performance
      • 8.4.12.3. Type Benchmarking
      • 8.4.12.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America esoteric testing market, by country, 2018 - 2030 (USD Million)
  • Table 3 North America esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 5 North America esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 6 U.S. esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 8 U.S. esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 11 Canada esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Mexico esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 13 Mexico esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 14 Mexico esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe esoteric testing market, by country, 2018 - 2030 (USD Million)
  • Table 16 Europe esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 17 Europe esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Europe esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 20 UK esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 21 UK esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Germany esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 23 Germany esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 24 Germany esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 25 France esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 26 France esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 27 France esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Italy esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 29 Italy esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 30 Italy esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Spain esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 32 Spain esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Spain esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Denmark esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 35 Denmark esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 36 Denmark esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Sweden esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 38 Sweden esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 39 Sweden esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Norway esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 41 Norway esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 42 Norway esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific esoteric testing market, by country, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Japan esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 48 Japan esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 49 Japan esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 50 China esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 51 China esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 52 China esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 53 India esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 54 India esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 55 India esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Australia esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 57 Australia esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 58 Australia esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 59 South Korea esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 60 South Korea esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 61 South Korea esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Thailand esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 63 Thailand esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 64 Thailand esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Latin America esoteric testing market, by country, 2018 - 2030 (USD Million)
  • Table 66 Latin America esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 67 Latin America esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Latin America esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Brazil esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 70 Brazil esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 71 Brazil esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 72 Argentina esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 73 Argentina esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 74 Argentina esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 75 Middle East & Africa esoteric testing market, by country, 2018 - 2030 (USD Million)
  • Table 76 Middle East & Africa esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 77 Middle East & Africa esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 78 Middle East & Africa esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 79 South Africa esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 80 South Africa esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 81 South Africa esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 82 South Arabia esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 83 South Arabia esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 84 South Arabia esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 85 UAE esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 86 UAE esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 87 UAE esoteric testing market, by end use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait esoteric testing market, by product, 2018 - 2030 (USD Million)
  • Table 89 Kuwait esoteric testing market, by technology, 2018 - 2030 (USD Million)
  • Table 90 Kuwait esoteric testing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Esoteric testing market: Market outlook
  • Fig. 10 Esoteric testing competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 Esoteric testing market driver impact
  • Fig. 16 Esoteric testing market restraint impact
  • Fig. 17 Esoteric testing market strategic initiatives analysis
  • Fig. 18 Esoteric testing market: Type movement analysis
  • Fig. 19 Esoteric testing market: Type outlook and key takeaways
  • Fig. 20 Oncology testing market estimates and forecast, 2018 - 2030
  • Fig. 21 Infectious disease testing market estimates and forecast, 2018 - 2030
  • Fig. 22 Genetic testing market estimates and forecast, 2018 - 2030
  • Fig. 23 Endocrinology testing market estimates and forecast, 2018 - 2030
  • Fig. 24 Toxicology testing market estimates and forecast, 2018 - 2030
  • Fig. 25 Neurology testing market estimates and forecast, 2018 - 2030
  • Fig. 26 Other market estimates and forecast, 2018 - 2030
  • Fig. 27 Esoteric testing market: Technology movement analysis
  • Fig. 28 Esoteric testing market: Technology outlook and key takeaways
  • Fig. 29 Chemiluminescence immunoassay market estimates and forecasts, 2018 - 2030
  • Fig. 30 Enzyme-linked immunosorbent assay market estimates and forecasts,2018 - 2030
  • Fig. 31 Mass spectrometry market estimates and forecasts, 2018 - 2030
  • Fig. 32 Real time polymerase chain reaction market estimates and forecasts, 2018 - 2030
  • Fig. 33 Flow cytometry market estimates and forecasts, 2018 - 2030
  • Fig. 34 Other market estimates and forecasts, 2018 - 2030
  • Fig. 35 Esoteric testing market: End use movement analysis
  • Fig. 36 Esoteric testing market: End use outlook and key takeaways
  • Fig. 37 Hospital-based laboratories esoteric testing market estimates and forecast, 2018 - 2030
  • Fig. 38 Independent and reference laboratories esoteric testing estimates and forecast, 2018 - 2030
  • Fig. 39 Global esoteric testing market: Regional movement analysis
  • Fig. 40 Global esoteric testing market: Regional outlook and key takeaways
  • Fig. 41 North America market estimates and forecasts, 2018 - 2030
  • Fig. 42 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 43 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 44 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 45 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 46 UK market estimates and forecasts, 2018 - 2030
  • Fig. 47 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 48 France market estimates and forecasts, 2018 - 2030
  • Fig. 49 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 50 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 51 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 52 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 53 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 54 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 55 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 56 China market estimates and forecasts, 2018 - 2030
  • Fig. 57 India market estimates and forecasts, 2018 - 2030
  • Fig. 58 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 59 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 60 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 61 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 62 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 63 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 64 Middle East & Africa (MEA) market estimates and forecasts, 2018 - 2030
  • Fig. 65 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 66 South Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 67 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 68 Kuwait market estimates and forecasts, 2018 - 2030